Kestra Advisory Services’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,600
Closed -$19.7K – 3448
2026
Q2
$19.7K Buy
+10,600
New +$20.6K ﹤0.01% 3237

Other funds holding ANVS

Kestra Advisory Services's ANVS Position: Q3 2026 in Review

Kestra Advisory Services sold out of Annovis Bio (ANVS) in Q3 2026, closing a stake of 10,600 shares — an estimated $19.7K sold.

Kestra Advisory Services first reported a position in ANVS in Q2 2026 and held it in 1 quarter. The position peaked at $19.7K in Q2 2026. 60 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • Kestra Advisory Services reported no remaining Annovis Bio position as of Q3 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 10,600 Annovis Bio shares in Q3 2026, an estimated $19.7K.
  • Kestra Advisory Services first reported a position in Annovis Bio in Q2 2026 and held it in 1 quarter.
  • Kestra Advisory Services's Annovis Bio position peaked at $19.7K in Q2 2026.
  • 60 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.